Donor origin de novo HCC in a noncirrhotic liver allograft 3 years after liver transplantation

Transplant International

Volumn 23, Issue 3, 2010, Pages 341-343

  Vernadakis, Spiridon ^a   Poetsch, Michaela ^b   Weber, Frank ^a   Treckmann, Jürgen ^a   Mathe, Zoltan ^a   Baba, Hideo A ^b   Paul, Andreas ^a   Kaiser, Gernot M ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ADULT; ALLOGRAFT; BILIARY TRACT DISEASE; BLOOD GROUP ABO SYSTEM; CASE REPORT; CAVA VEIN; CHOLANGITIS; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; FOLLOW UP; GRAFT REJECTION; HISTOPATHOLOGY; HUMAN; LETTER; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MALE; MEDICAL RECORD; MICROSATELLITE MARKER; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN DONOR; PRIORITY JOURNAL;

AGED; CADAVER; CARCINOMA, HEPATOCELLULAR; HUMANS; IMMUNOSUPPRESSION; LIVER CIRRHOSIS, ALCOHOLIC; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; TIME FACTORS; TISSUE DONORS;

EID: 75149114146     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2009.00942.x     Document Type: Letter

References (11)

1. Sanchez EQ, Murabashi S, Jung G, et al. De novo tumors after liver transplantation: a single-institution experience. Liver Transpl 2002 8: 285.
2. Yao FY, Gautam M, Palese C, et al. De novo malignancies following liver transplantation: a case-control study with long-term follow-up. Clin Transplant 2006 20: 617.
3. Fung JJ, Jain A, Kwak EJ, Kusne S, Dvorchik I, Eghtesad B. De novo malignancies after liver transplantation: a major cause of late death. Liver Transpl 2001 7 (Suppl. 1 109.
4. Frezza EE, Fung JJ, van Theil DH. Non-lymphoid cancer after liver transplantation. Hepatogastroenterology 1997 44: 1172.
5. Penn I. Posttransplant malignancies. Transplant Proc 1999 31: 1260.
6. Peyregne V, Ducerf C, Adham M, et al. De novo cancer after orthotopic liver transplantation. Transplant Proc 1998 30: 1484.
7. Sotiropoulos GC, Frilling A, Molmenti EP, et al. De novo hepatocellular carcinoma in recurrent liver cirrhosis after liver transplantation for benign hepatic disease: is a deceased donor re-transplantation justified? Transplantation 2006 82: 1112.
8. Saxena R, Ye MQ, Emre S, Klion F, Nalesnik MA, Thung SN. De novo hepatocellular carcinoma in a hepatic allograft with recurrent hepatitis C cirrhosis. Liver Transpl Surg 1999 5: 81.
9. Flemming P, Tillmann HL, Barg-Hock H, et al. Donor origin of de novo hepatocellular carcinoma in hepatic allografts. Transplantation 2003 76: 871.
10. Chan SC, Cheung ST, Leung SY, Liu CL, Fan ST, Lo CM. De novo sarcoma of donor origin in a liver allograft determined by microsatellite analysis: a short report. Liver Transpl 2004 10: 320.
11. Mas VR, Maluf DG, Dumur CI, et al. Molecular techniques for identifying HCC origin and biology after orthotopic liver transplantation. Diagn Mol Pathol 2006 15: 90.